Following decades of limited treatment options, people living with fibromyalgia will soon have access to a novel therapy designed to tackle the condition’s most elusive symptom: Poor-quality sleep. The US Food and Drug Administration (FDA) has just approved Tonmya, a non-opioid, under-the-tongue bedtime treatment for fibromyalgia in adults, which is expected to be widely available within months. It’s the first drug approved for this complex and debilitating condition in more than 15 years...
